tiprankstipranks
Krystal Biotech sees FY24 non-GAAP R&D, SG&A expense $115M-$125M
PremiumThe FlyKrystal Biotech sees FY24 non-GAAP R&D, SG&A expense $115M-$125M
19d ago
Is KRYS a Buy, Before Earnings?
Premium
Pre-Earnings
Is KRYS a Buy, Before Earnings?
21d ago
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
Premium
The Fly
Intellia Therapeutics price target lowered to $64 from $80 at Stifel
2M ago
Krystal Biotech price target raised to $221 from $200 at H.C. Wainwright
PremiumThe FlyKrystal Biotech price target raised to $221 from $200 at H.C. Wainwright
3M ago
Krystal Biotech could see ‘incremental boost’ on PEARL-1 data, says Stifel
Premium
The Fly
Krystal Biotech could see ‘incremental boost’ on PEARL-1 data, says Stifel
3M ago
Krystal unit Jeune provides efficacy results from PEARL-1 study of COL3
Premium
The Fly
Krystal unit Jeune provides efficacy results from PEARL-1 study of COL3
3M ago
Is KRYS a Buy, Before Earnings?
PremiumPre-EarningsIs KRYS a Buy, Before Earnings?
4M ago
Krystal Biotech participates in a conference call with Cantor Fitzgerald
Premium
The Fly
Krystal Biotech participates in a conference call with Cantor Fitzgerald
4M ago
Krystal Biotech, Virtu, StepStone, Cactus Inc., Tidewater to join S&P 600
Premium
The Fly
Krystal Biotech, Virtu, StepStone, Cactus Inc., Tidewater to join S&P 600
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100